Laurus Labs has signed an agreement with MPP (Medicine Patient Pool). The agreement is for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.